This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

EHCT Stock Overview

European Healthcare Acquisition & Growth Company B.V. More details

EHCT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Rewards

Became profitable this year

Risk Analysis

Makes less than USD$1m in revenue (€0)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

European Healthcare Acquisition & Growth Company B.V. Competitors

Value8

ENXTAM:VALUE

€57.6m

Van Lanschot Kempen

ENXTAM:VLK

€2.4b

CVC Capital Partners

ENXTAM:CVC

€17.7b

Flow Traders

ENXTAM:FLOW

€1.2b

Price History & Performance

Summary of share price highs, lows and changes for European Healthcare Acquisition & Growth Company B.V
Historical stock prices
Current Share Price	€0.01
52 Week High	€0
52 Week Low	€0
Beta	-0.065
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	EHCT	NL Capital Markets	NL Market
7D	0%	1.3%	3.6%
1Y	0%	-2.8%	-4.4%

Return vs Industry: EHCT underperformed the Dutch Capital Markets industry which returned 9.4% over the past year.

Return vs Market: EHCT underperformed the Dutch Market which returned 7.4% over the past year.

Price Volatility

Is EHCT's price volatile compared to industry and market?
EHCT volatility
EHCT Average Weekly Movement	0%
Capital Markets Industry Average Movement	5.3%
Market Average Movement	5.2%
10% most volatile stocks in NL Market	9.9%
10% least volatile stocks in NL Market	3.1%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine EHCT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2021	n/a	Thomas Rudolph	www.ehc-company.com

European Healthcare Acquisition & Growth Company B.V. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more companies or businesses. It focuses on acquiring companies or businesses in the healthcare sector with a focus on biotechnology and specialty pharma, pharma services, medical technology and medical devices, diagnostic and lab services, and bioinformatics, as well as life science tools subsectors in Europe.

European Healthcare Acquisition & Growth Company B.V. Fundamentals Summary

How do European Healthcare Acquisition & Growth Company B.V's earnings and revenue compare to its market cap?
EHCT fundamental statistics
Market cap	€182.00m
Earnings (TTM)	€3.74m
Revenue (TTM)	n/a

48.7x

P/E Ratio

0.0x

P/S Ratio

Is EHCT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EHCT income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	-€3.74m
Earnings	€3.74m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.19
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0%

How did EHCT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/11/30 03:54
End of Day Share Price	2024/11/28 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

European Healthcare Acquisition & Growth Company B.V. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

European Healthcare Acquisition & Growth Company B.V ENXTAM:EHCT Stock Report